NCT04501640View on ClinicalTrials.gov

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

October 14, 2020

Study Completion Date

October 27, 2020

Conditions
Pharmacokinetics of MirabegronFood EffectHealthy Chinese Subjects
Interventions
DRUG

mirabegron

Oral adminstration

Trial Locations (1)

Unknown

Site CN86001, Shanghai

All Listed Sponsors
lead

Astellas Pharma China, Inc.

INDUSTRY

NCT04501640 - A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants | Biotech Hunter | Biotech Hunter